Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes

被引:189
作者
Elliott, JI
Surprenant, A
Marelli-Berg, FM
Cooper, JC
Cassady-Cain, RL
Wooding, C
Linton, K
Alexander, DR
Higgins, CF
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, Ctr Clin Sci, London W12 0NN, England
[2] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Immunol, London W12 0NN, England
[3] Univ Sheffield, Dept Biomed Sci, Inst Mol Physiol, Sheffield S10 2TN, S Yorkshire, England
[4] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB2 4AT, England
[5] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
基金
英国医学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
D O I
10.1038/ncb1279
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Phosphatidylserine (PS) exposure is normally associated with apoptosis and the removal of dying cells. We observed that PS is exposed constitutively at high levels on T lymphocytes that express low levels of the transmembrane tyrosine phosphatase CD45RB. CD45 was shown to be a negative regulator of PS translocation in response to various signals, including activation of the ATP receptor P2X(7). Changes in PS distribution were shown to modulate several membrane activities: Ca2+ and Na+ uptake through the P2X(7) cation channel itself; P2X(7)-stimulated shedding of the homing receptor CD62L; and reversal of activity of the multidrug transporter P-glycoprotein. The data identify a role for PS distribution changes in signal transduction, rapidly modulating the activities of several membrane proteins. This seems to be an all-or-none effect, coordinating the activity of most or all the molecules of a target protein in each cell. The data also suggest a new approach to circumventing multidrug resistance.
引用
收藏
页码:808 / U76
页数:13
相关论文
共 44 条
[1]   Cutting edge: A natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor [J].
Adriouch, S ;
Dox, C ;
Welge, V ;
Seman, M ;
Koch-Nolte, F ;
Haag, F .
JOURNAL OF IMMUNOLOGY, 2002, 169 (08) :4108-4112
[2]   Aminophospholipid asymmetry: A matter of life and death [J].
Balasubramanian, K ;
Schroit, AJ .
ANNUAL REVIEW OF PHYSIOLOGY, 2003, 65 :701-734
[3]   Lipid translocation across the plasma membrane of mammalian cells [J].
Bevers, EM ;
Comfurius, P ;
Dekkers, DWC ;
Zwaal, RFA .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1999, 1439 (03) :317-330
[4]   Involvement of phosphatidylinositol 4,5-bisphosphate in phosphatidylserine exposure in platelets: Use of a permeant phosphoinositide-binding peptide [J].
Bucki, R ;
Janmey, PA ;
Vegners, R ;
Giraud, F ;
Sulpice, JC .
BIOCHEMISTRY, 2001, 40 (51) :15752-15761
[5]   CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4(+)CD8(+) thymocytes, and in B cell maturation [J].
Byth, KF ;
Conroy, LA ;
Howlett, S ;
Smith, AJH ;
May, J ;
Alexander, DR ;
Holmes, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1707-1718
[6]  
Castedo M, 1996, J IMMUNOL, V157, P512
[7]  
CONNOR J, 1994, J BIOL CHEM, V269, P2399
[8]   Multidrug transporter activity in lymphocytes [J].
Elliott, JI ;
Raguz, S ;
Higgins, CF .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (07) :899-907
[9]   Major histocompatibility complex class I shedding and programmed cell death stimulated through the proinflammatory P2X7 receptor -: A candidate susceptibility gene for NOD diabetes [J].
Elliott, JI ;
Higgins, CF .
DIABETES, 2004, 53 (08) :2012-2017
[10]   A receptor for phosphatidylserine-specific clearance of apoptotic cells [J].
Fadok, VA ;
Bratton, DL ;
Rose, DM ;
Pearson, A ;
Ezekewitz, RAB ;
Henson, PM .
NATURE, 2000, 405 (6782) :85-90